Lee June Yong, Yang Misuk, Jeong Kyoung Yong, Sim Da Woon, Park Jin Hee, Park Kyung Hee, Lee Jae-Hyun, Park Jung-Won
Department of Internal Medicine, Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea.
Int Arch Allergy Immunol. 2017;174(2):77-85. doi: 10.1159/000481092. Epub 2017 Oct 25.
Oaks are the most common trees in Korean forests, and Mongolian oak, Quercus mongolica, is the dominant species. However, no allergen has been characterized from Mongolian oak. In this study, we tried to characterize a major allergen from Mongolian oak.
A molecule homologous to pathogenesis-related 10 (PR-10)-like protein, Que m 1, was cloned by RT-PCR. Its recombinant protein, along with Que a 1, an allergen from white oak (Q. alba), was produced. The allergenicity and diagnostic value of recombinant Que m 1, Que a 1, and Bet v 1 proteins were compared by ELISA using sera from oak-sensitized subjects. A basophil activation test was also performed using CD63 expression as an activation marker.
Que m 1 sequence shares 57.5-96.2% amino acid sequence identity with PR-10-like allergens from various plants. Specific IgE to recombinant Que m 1, Que a 1, and Bet v 1 were detected in 92.0, 74.0, and 38.0% of 50 serum samples from Korean tree pollinosis patients. Recombinant Que m 1 was able to inhibit IgE reactivity to Que a 1 and Bet v 1, indicating its strong cross-reactivity. The activation patterns of basophils from 5 patients were similar in terms of the CD63 expression and protein concentration of challenged Bet v 1 and Que m 1.
A major allergen, Que m 1, was cloned, and its recombinant protein was produced from Mongolian oak, a dominant species in Korea. Recombinant Que m 1 is potentially useful for the diagnosis and treatment of tree pollinosis in Korea.
橡树是韩国森林中最常见的树木,其中蒙古栎(Quercus mongolica)是优势树种。然而,蒙古栎的过敏原尚未得到鉴定。在本研究中,我们试图鉴定蒙古栎的一种主要过敏原。
通过逆转录聚合酶链反应(RT-PCR)克隆了一种与病程相关蛋白10(PR-10)样蛋白同源的分子Que m 1。制备了其重组蛋白,以及来自白栎(Q. alba)的过敏原Que a 1。使用橡树致敏患者的血清,通过酶联免疫吸附测定(ELISA)比较重组Que m 1、Que a 1和Bet v 1蛋白的致敏性和诊断价值。还以CD63表达作为激活标志物进行了嗜碱性粒细胞活化试验。
Que m 1序列与来自各种植物的PR-10样过敏原的氨基酸序列同一性为57.5%-96.2%。在50份韩国花粉症患者的血清样本中,分别有92.0%、74.0%和38.0%检测到针对重组Que m 1、Que a 1和Bet v 1的特异性免疫球蛋白E(IgE)。重组Que m 1能够抑制IgE与Que a 1和Bet v 1的反应性,表明其具有很强的交叉反应性。5名患者的嗜碱性粒细胞在受到攻击的Bet v 1和Que m 1的CD63表达和蛋白浓度方面的激活模式相似。
克隆了一种主要过敏原Que m 1,并从韩国优势树种蒙古栎中制备了其重组蛋白。重组Que m 1可能对韩国花粉症的诊断和治疗有用。